The study identified significant associations between the CpG site cg08806558 at the IGF1 promoter and AD features, such as Braak stages and amyloid plaques, suggesting IGF-1’s role in β-amyloid clearance (175). The gene discussed is IGF1; the disease is Alzheimer disease.